Canada markets closed

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.5200-0.0100 (-0.65%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.73M
Enterprise Value 7.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.07
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.51

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-64.42%
S&P500 52-Week Change 326.36%
52 Week High 35.5000
52 Week Low 31.0780
50-Day Moving Average 31.5622
200-Day Moving Average 32.8327

Share Statistics

Avg Vol (3 month) 317.36k
Avg Vol (10 day) 314.7k
Shares Outstanding 57.92M
Implied Shares Outstanding 65.06M
Float 89.56B
% Held by Insiders 12,017.91%
% Held by Institutions 12.28%
Shares Short (Apr 30, 2024) 42.21k
Short Ratio (Apr 30, 2024) 40.12
Short % of Float (Apr 30, 2024) 40.05%
Short % of Shares Outstanding (Apr 30, 2024) 40.03%
Shares Short (prior month Mar 28, 2024) 410.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug 17, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-210.95%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.18M
Net Income Avi to Common (ttm)-16.57M
Diluted EPS (ttm)-2.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.31M
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.44
Book Value Per Share (mrq)-0.44

Cash Flow Statement

Operating Cash Flow (ttm)-15.6M
Levered Free Cash Flow (ttm)-9.76M